INHALATIONAL ANAESTHETICS: VOLATILE



INHALATIONAL ANAESTHETICS: VOLATILE
Characteristics
DIETHYL ETHER
HALOTHANE
METHOXY FLURANE (M.F)
ENFLURANE
ISOFLURANE
Cost
CLASSICAL General anesthetic
Cheaper, simple method of administration( post operative nausea and vomition)
Expensive, Complex method of  (semiclosed and closed) administration               (No post operative nausea and vomition)
Expensive
More expensive than halothane.
Complex method of administration
Very expensive than others, complex method of administration
Boiling point (0C)
35
50
101
57
48.5
MAC(%)
2-3
0.75-1.1
0.23
1.5
1.5
Amount of metabolism (% of administered dose)
<20%
15-20%
50-70
2-5
0.2
Stability
Decomposes (oxidized to peroxides) on  exposure  to air, heat, light, moisture. Not to be kept in fridge. To be stored in well stoppered amber coloured bottle
Decomposes on  exposure  to light to form volatile acid.
0.01% thymol is stabilizing agent used.
Decomposes on exposure  to light.
Butylated hydroxyl toluene is preservative
Very stable. No preservative required
Structural analog of M.F
Very stable. No preservative required
Stability in
Sodalime
UV Light

Decomposes
Decomposes

Decomposes
Decomposes

Decomposes
Decomposes

Stable
Stable

Stable
Stable
Stages of anesthesia induced
I,II,III,IV
I, III,IV
I, III,IV
I,II- Seizures                         ( Convulsant anaesthetic)
I,II – Dissociative anaesthesia
Effect on CNS
(Anaesthesia induction)
Satisfactory Slow induction and recovery due to high solubility in blood ( HiGH Lipid water partition coefficient)

Rapid induction and recovery ,
Moderate degree of  solubility in blood
Slow induction and slow recovery
Rapid induction and recovery
Increased CNS irritability, cortical hyper excitability
Very Rapid induction and recovery faster than halothane and others
Reduced  CNS irritability and  cortical hyper excitability
Effect on CardioVascular System (CVS)
Increases epinephrine release- increased BP, heart rate, vasomotor centre depression followedby cardiac arrythmias
Initially increased heart rate, later – myocardial depressant- reduced BP, Heart rate. Sensitizes heart to catecholamines (epinephrine is to be avoided),cardiac arrhythmias during induction
Hypotension, cardiac depression, no change in heart rate.
Cardiac depression equivalent to halothane
Cardiac depression less than enflurane.
Effect on Respiratoy system
Mucous membrane irritant, increased mucous secretion, hyperventilation- results in  respiratory alkalosis, hypoventilation results in acidosis                  ( Atropine is used to prevent)
Non irritant
Reduced ventilation- Co2 accumulation- result in resp.  acidosis
Non irritant
Reduced ventilation- Co2 accumulation- result in resp.  acidosis
Dose dependent respiratory depression.
Respiratory depression Similar to that of halothane
Effect on body temperature
Hypothermia
Malignant hyperthermia in pig, horse, man                (Dantrolene sodium - antidote)
Hypothermia
Hypothermia
Malignant hyperthermia in pig, horse, man (Dantrolene sodium - antidote)
Effect on Kidney/Urinary system
Release ADH, oliguria/anuria
Temporary reduction in urine volume.
Temporary reduction in urine volume.
Reduced renal blood flow, GFR and urine volume
No effect
Muscle relaxation and analgesia
Satisfactory muscle relaxation and analgesia. Motor end plate/ Neuromuscular blockade – Skeletal muscle paralysis- Curariform effect
Adequate muscle relaxation and analgesia.
Excellent muscle relaxation and analgesia., preferred for abdominal surgeries
Incomplete muscle relaxation and poor to moderate analgesia.
Twitching of facial, neck and limb muscles.
Adequate muscle relaxation and analgesia.
Hepatotoxicity
Reduced glycogen synthesis, Hepatotoxic
Hepatotoxic
Nontoxic
Nontoxic
Nontoxic
Renal/Nephro toxicity
Nontoxic
Nontoxic
Potent nephrotoxic
Nontoxic
Nontoxic
Effect on uterus
Relaxation of uterine smooth muscle, reduced tone and motility
reduced tone and motility (not to be used in obstetrical anesthesia)
high dose- fetal respiratory depression


Do not saffect tone and motility, no untoward effect on fetus
Relaxant effect similar to that of halothane
Relaxant effect similar to that of halothane
Side/ Adverse effects
Initial excitement, cardiopulm. depression, hypoventilation , respiratory paralysis
Vasodilation, hypotension, arrhythmias, malignant hyperthermia
Nephrotoxicity. Dose dependent CV &resp. depression
Resp. & CV depression, twitching of face, neck, limb muscles; Ocassional tonic-clonic seizures
Mild hypotension, tachycardia
Drug interactions
Potentiate  any other CNS depressants actions, NMBD-
Potentiate Nondepolarising neuromuscular blocking drugs(NMBD), and ganglionic blockers action. Avoided with aminoglycosides and paracetamol
To be avoided in combination  with nephrotoxic drugs  like:aminoglycosides, NSAIDS, loop diuretics, NMBD, epinephrine(increased chance of arythmias)
Similar to that of halotahne
Not much significant interaction
Contraindications(CI) and Precautions
Acute and chronic respiratory  diseases, acidosis, shock, surgery requiring electrocautery, flammable device to  be avoided
Cardiac diseases, Congestive heart failure, liver diseases, precaution in – increased  intraocular pressure, CSF conc.(head injury), pheochromocytoma)
CI- in renal, hepatic injury and head injury
Not recommended in horses, patients with history of epilepsy, abnormalities in EEG
Cautious in respiratory  or cardiac failure patients
Clinical use in animals
Pig, dog, cat, calves, lab animals
Externally used as rubefacient, cleansing agent
Orally – has antispasmodic, carminative, stimulant action on heart
Maintenance anesthetic in horse, dog, cats
Maintenance anesthetic in horse, dog, cats
As alternative to halothane as maintenance  anesthetic in horse, dog, cats
Anesthetic choice for debilitated, aged,  hepatically, renally  impaired  patients
Indications and combinations used
a)with pentobarbitone 
b)with morphine, pethidine(atropine –preanaesthetic) to provide balanced anesthesia
a)with nitrous oxide+oxygen(to reduce cardiopulmonary depression) 
b)with  xylazine/acepromazine for both inducation and maintenanace

a)with nitrous oxide(70%)
 b) with pentobarbitone
 withdrawn  nowadays
a)with nitrous oxide(70%)
b) diazepam
 c) thiobarbitone sodium
d) ethosuximide(to increase seizure threshold)
a) with barbiturates
(thiopentone
/pentobarb itone)
b) nitrous oxide(50%)

Dose
Induction-: 10-40%
Maintenance: 3-12%
Induction-: 2-4%
Maintenance:
Small animals: 0.5-1.5%
LA: 1-2%
Induction-: 1-3%
Maintenance:
Small animals: 0.5-1.5%
LA:  0.5%
Induction-:  4-6%
Maintenance:
1-3%
Induction-: 2.5-4.5%
Maintenance:
1-3%
Malignant hyperthermia (MH) or malignant hyperpyrexia
·         A rare  life-threatening condition that is usually triggered by exposure to certain drugs used for general anesthesia, specifically the volatile anesthetic agents and the neuromuscular blocking agent,succinylcholine.
·         In susceptible individuals, these drugs can induce a drastic and uncontrolled increase in skeletal muscle oxidative metabolism, which overwhelms the body's capacity to supply oxygen, remove carbon dioxide, and regulate body temperature, eventually leading to circulatory collapse and death if not treated quickly.
·          Susceptibility to MH is often inherited as an autosomal dominant disorder, for which there are at least 6 genetic loci of interest,[2] most prominently the ryanodine receptor gene (RYR1). 
·         In the anesthetic induced malignant hyperthermia syndrome, : "triggering agents" induce a sudden rise in myoplasmic calcium either by preventing the sarcoplasmic reticulum from accumulating calcium adequately, or by accelerating its release. This rise in myoplasmic calcium activates acute catabolic processes common to the malignant hyperthermia crisis. 
·          Treatment with dantrolene sodium is usually initiated;  Dantrolene may prevent the increase in myoplasmic calcium and the acute catabolism within the muscle cell by interfering with the release of calcium from the sarcoplasmic reticulum to the myoplasm. Thus, the physiologic, metabolic and biochemical changes associated with the crisis may be reversed or attenuated.
SEVOFLURANE -  Anesthetic for  use in pigs
DESFLURANE: Fluorinated congener of isoflurane
ETHYL CHLORIDE- Volatile anesthetic used in  sprays for local anaesthetic, analgesic effect in sport injuries
CHLOROFORM
  • Unpleasant odour – Powerful rapid inducer, Noninflammabla, explosive
  •  Used to produce euthanasia  for killing street dogs
  • Sensitizes myocardium to adrenaline ventricular fibrillation sudden death (20 – 30 times more potent than ether)
  • Produce phosgene which is highly irritant
  • Nephrotoxic and Hepatotoxic- central tubular liver  necrosis, fatty degeneration of heart and kidney
  •  Discontinued nowadays

INHALATIONAL :   GASEOUS ANAESTHEICS
NITROUS OXIDE (laughing gas)
  • N2O increases pulmonary ventilation – due to direct stimulation of respiration.
  • Increases  its own inhalation – (Concentration effect)  and also that of halothane or enflurane or oxygen when given together (second gas effect)
  • MAC > 100% (104 in man to 255 in cat) – weak anaesthetic,   Poor muscle relaxation, But strongly analgesic
  •  Used in combination with oxygen to avoid induction of hypoxia ( 30% + oxygen 70%)
  • Used as an anaesthetic adjuvant- as maintenance anesthetic  in horse, pig, ruminants, dogs, cats

Other gases: ETHYLENE, CYCLOPROPANE (TRIMETHYLENE) and   XENON

Comments

Popular posts from this blog

Pharmacokinetics - Drug absorption and Transport of drugs across biological membranes

Skeletal muscle relaxants

PHARMACOGNOSY - SOURCES AND COMPOSITION OF DRUGS